Hervana Overview

  • Founded
  • 2008

Founded
  • Status
  • Private

  • Employees
  • 3

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $997K

  • Investors
  • 1

Hervana General Information

Description

Developer of female non-hormonal contraceptives. The company develops a sperm motility-inhibiting probiotic agent which prevents fertilization and also protects against sexually transmitted diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Primary Office
  • Naftali 9/8
  • Jerusalem
  • Israel
+972 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hervana Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 04-Jun-2012 $997K Completed Generating Revenue
2. Grant 01-May-2010 00000 Completed Startup
1. Angel (individual) Completed Startup
To view Hervana’s complete valuation and funding history, request access »

Hervana Patents

Hervana Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2566490-B1 Biologic female contraceptives Active 06-May-2010 000000000
CA-2797082-A1 Lactobacillus engineered to express an anti-sperm antibody as female contraceptive Pending 06-May-2010 000000000
AU-2015252159-B2 Biologic female contraceptives Inactive 06-May-2010 000000000
AU-2015252159-A1 Biologic female contraceptives Active 06-May-2010 000000000
ES-2671345-T3 Biological female contraceptives Active 06-May-2010 A61K35/74
To view Hervana’s complete patent history, request access »

Hervana Executive Team (3)

Name Title Board Seat Contact Info
Rachel Teitelbaum Ph.D Founder & Co-Chief Executive Officer
David Zakai Chief Operating Officer, Vice President, Business Development & Chief Business Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Hervana Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hervana Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view Hervana’s complete investors history, request access »